EXAS
Exact Sciences Corp
Price Chart
No historical data available
Latest Quote
$104.91
+0.00 (+0.00%)
Current Price
| Previous Close | $104.91 |
| Open | $104.93 |
| Day High | $104.98 |
| Day Low | $104.90 |
| Volume | 21,562,141 |
Stock Information
| Shares Outstanding | 190.89M |
| Total Debt | $2.53B |
| Cash Equivalents | $964.71M |
| Revenue | $3.25B |
| Net Income | $-207.95M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $20.03B |
| EPS (TTM) | $-1.10 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Exact Sciences Corp
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer; Cologuard Plus Tests; Cancerguard Test; and Genetic Testing. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; Oncodetect Test;OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University, as well as Freenome Holdings, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
đ° Latest News
Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences
Insider Monkey âĸ 2026-03-26T15:50:39Z
Abbott closes $23 billion deal to buy Madison-based Exact Sciences
Milwaukee Journal Sentinel âĸ 2026-03-24T10:05:54Z
Clearwater Analytics Stock Lands $37 Million Investment Amid 77% ARR Growth Surge and Pending Buyout
Motley Fool âĸ 2026-03-22T16:06:47Z
This $19.8 Million Bet on Commvault Comes Amid a 51% Drop. Hereâs What Investors Should Know
Motley Fool âĸ 2026-03-22T13:10:05Z
How Walgreensâ Pharmacy-Led Cologuard Expansion At Exact Sciences (EXAS) Has Changed Its Investment Story
Simply Wall St. âĸ 2026-03-22T04:15:56Z
Abbott to close $21B Exact Sciences acquisition Monday
MedTech Dive âĸ 2026-03-20T10:57:54Z
1 Mid-Cap Stock to Consider Right Now and 2 Facing Headwinds
StockStory âĸ 2026-03-17T19:12:30Z
Hedge Fund Beryl Capital Initiated a Position in CSG Systems Worth Over $54 Million. Is the Stock a Buy?
Motley Fool âĸ 2026-03-11T18:28:00Z
Exact Sciences Case Study Links Higher Screening Rates With Undervalued Shares
Simply Wall St. âĸ 2026-03-10T05:08:33Z
3 Cash-Producing Stocks We Approach with Caution
StockStory âĸ 2026-03-06T12:19:37Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $984,235,000 | $840,150,000 | $737,564,000 | $661,361,000 |
| Cost Of Revenue | $984,235,000 | $840,150,000 | $737,564,000 | $661,361,000 |
| Total Revenue | $3,246,990,000 | $2,758,867,000 | $2,499,766,000 | $2,084,279,000 |
| Operating Revenue | $3,246,990,000 | $2,758,867,000 | $2,499,766,000 | $2,084,279,000 |
| Expenses | ||||
| Interest Expense | $34,752,000 | $31,974,000 | $24,421,000 | $13,907,000 |
| Total Expenses | $3,446,088,000 | $2,938,110,000 | $2,714,157,000 | $2,661,821,000 |
| Other Income Expense | $34,571,000 | $-819,648,000 | $42,416,000 | $-35,394,000 |
| Net Non Operating Interest Income Expense | $-39,361,000 | $-37,270,000 | $-29,771,000 | $-19,634,000 |
| Total Other Finance Cost | $4,609,000 | $5,296,000 | $5,350,000 | $5,727,000 |
| Interest Expense Non Operating | $34,752,000 | $31,974,000 | $24,421,000 | $13,907,000 |
| Operating Expense | $2,461,853,000 | $2,097,960,000 | $1,976,593,000 | $2,000,460,000 |
| Selling And Marketing Expense | $1,050,183,000 | $894,125,000 | $827,805,000 | $929,644,000 |
| General And Administrative Expense | $888,674,000 | $781,825,000 | $800,288,000 | $663,381,000 |
| Other Operating Expenses | - | $-9,200,000 | $-78,427,000 | $13,244,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-207,949,000 | $-1,028,857,000 | $-204,149,000 | $-623,506,000 |
| Net Interest Income | $-39,361,000 | $-37,270,000 | $-29,771,000 | $-19,634,000 |
| Normalized Income | $-235,260,090 | $-214,126,888 | $-237,657,640 | $-588,572,122 |
| Net Income From Continuing And Discontinued Operation | $-207,949,000 | $-1,028,857,000 | $-204,149,000 | $-623,506,000 |
| Total Operating Income As Reported | $-206,298,000 | $-1,048,703,000 | $-215,012,000 | $-593,511,000 |
| Net Income Common Stockholders | $-207,949,000 | $-1,028,857,000 | $-204,149,000 | $-623,506,000 |
| Net Income | $-207,949,000 | $-1,028,857,000 | $-204,149,000 | $-623,506,000 |
| Net Income Including Noncontrolling Interests | $-207,949,000 | $-1,028,857,000 | $-204,149,000 | $-623,506,000 |
| Net Income Continuous Operations | $-207,949,000 | $-1,028,857,000 | $-204,149,000 | $-623,506,000 |
| Pretax Income | $-203,888,000 | $-1,036,161,000 | $-201,746,000 | $-632,570,000 |
| Special Income Charges | $-7,200,000 | $-859,206,000 | $9,703,000 | $-15,969,000 |
| Operating Income | $-199,098,000 | $-179,243,000 | $-214,391,000 | $-577,542,000 |
| Gross Profit | $2,262,755,000 | $1,918,717,000 | $1,762,202,000 | $1,422,918,000 |
| Depreciation Amortization Depletion Income Statement | - | $7,700,000 | $92,160,000 | $97,450,000 |
| Depreciation And Amortization In Income Statement | - | $7,700,000 | $92,160,000 | $97,450,000 |
| Amortization Of Intangibles Income Statement | - | $7,700,000 | $92,160,000 | $97,450,000 |
| Per Share | ||||
| Diluted EPS | $-1.10 | $-5.59 | $-1.13 | $-3.54 |
| Basic EPS | $-1.10 | $-5.59 | $-1.13 | $-3.54 |
| Other | ||||
| Tax Effect Of Unusual Items | $7,259,910 | $-4,917,888 | $8,907,360 | $-460,122 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $17,872,000 | $30,320,000 | $-13,133,000 | $-385,711,000 |
| Total Unusual Items | $34,571,000 | $-819,648,000 | $42,416,000 | $-35,394,000 |
| Total Unusual Items Excluding Goodwill | $34,571,000 | $-819,648,000 | $42,416,000 | $-35,394,000 |
| Reconciled Depreciation | $221,579,000 | $214,859,000 | $206,608,000 | $197,558,000 |
| EBITDA (Bullshit earnings) | $52,443,000 | $-789,328,000 | $29,283,000 | $-421,105,000 |
| EBIT | $-169,136,000 | $-1,004,187,000 | $-177,325,000 | $-618,663,000 |
| Diluted Average Shares | $188,688,000 | $184,197,000 | $180,144,000 | $176,351,000 |
| Basic Average Shares | $188,688,000 | $184,197,000 | $180,144,000 | $176,351,000 |
| Diluted NI Availto Com Stockholders | $-207,949,000 | $-1,028,857,000 | $-204,149,000 | $-623,506,000 |
| Tax Provision | $4,061,000 | $-7,304,000 | $2,403,000 | $-9,064,000 |
| Impairment Of Capital Assets | $7,200,000 | $869,460,000 | $621,000 | $15,969,000 |
| Gain On Sale Of Security | $41,771,000 | $39,558,000 | $32,713,000 | $-19,425,000 |
| Research And Development | $522,996,000 | $431,210,000 | $426,927,000 | $394,191,000 |
| Selling General And Administration | $1,938,857,000 | $1,675,950,000 | $1,628,093,000 | $1,593,025,000 |
| Other Gand A | $888,674,000 | $781,825,000 | $800,288,000 | $663,381,000 |
| Other Special Charges | - | $-10,254,000 | $-10,324,000 | - |
| Amortization | - | $7,700,000 | $92,160,000 | $97,450,000 |
| Salaries And Wages | - | $1,001,400,000 | $977,800,000 | $989,500,000 |
Fetched: 2026-03-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-886,921,000 | $-974,120,000 | $-1,112,211,000 | $-1,259,118,000 |
| Total Assets | $5,860,629,000 | $5,928,139,000 | $6,471,334,000 | $6,226,873,000 |
| Total Non Current Assets | $4,304,780,000 | $4,356,716,000 | $5,276,965,000 | $5,244,616,000 |
| Other Non Current Assets | $185,811,000 | $169,722,000 | $177,387,000 | $90,577,000 |
| Goodwill And Other Intangible Assets | $3,287,973,000 | $3,376,369,000 | $4,257,516,000 | $4,302,280,000 |
| Other Intangible Assets | $919,925,000 | $1,009,693,000 | $1,890,396,000 | $1,956,240,000 |
| Current Assets | $1,555,849,000 | $1,571,423,000 | $1,194,369,000 | $982,257,000 |
| Other Current Assets | $126,284,000 | $122,046,000 | $85,627,000 | $73,898,000 |
| Inventory | $166,201,000 | $162,383,000 | $127,475,000 | $118,259,000 |
| Receivables | $298,653,000 | $248,968,000 | $203,623,000 | $158,043,000 |
| Accounts Receivable | $298,653,000 | $248,968,000 | $203,623,000 | $158,043,000 |
| Cash Cash Equivalents And Short Term Investments | $964,711,000 | $1,038,026,000 | $777,644,000 | $632,057,000 |
| Cash And Cash Equivalents | $955,996,000 | $600,889,000 | $605,378,000 | $242,493,000 |
| Cash Equivalents | $0 | $5,341,000 | $75,278,000 | $64,325,000 |
| Cash Financial | $955,996,000 | $595,548,000 | $530,100,000 | $178,168,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $1,371,181,000 | $1,969,331,000 | $1,758,898,000 | $1,993,613,000 |
| Total Debt | $2,522,699,000 | $2,754,758,000 | $2,554,725,000 | $2,446,871,000 |
| Long Term Debt And Capital Lease Obligation | $2,489,108,000 | $2,478,200,000 | $2,475,346,000 | $2,418,505,000 |
| Long Term Debt | $2,327,177,000 | $2,321,067,000 | $2,314,276,000 | $2,236,106,000 |
| Current Debt And Capital Lease Obligation | $33,591,000 | $276,558,000 | $79,379,000 | $28,366,000 |
| Current Debt | - | $249,153,000 | $50,000,000 | - |
| Other Current Borrowings | - | $249,153,000 | $50,000,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,459,577,000 | $3,525,890,000 | $3,326,029,000 | $3,183,711,000 |
| Total Non Current Liabilities Net Minority Interest | $2,818,425,000 | $2,793,703,000 | $2,811,328,000 | $2,770,964,000 |
| Other Non Current Liabilities | $329,317,000 | $315,503,000 | $335,982,000 | $352,459,000 |
| Current Liabilities | $641,152,000 | $732,187,000 | $514,701,000 | $412,747,000 |
| Other Current Liabilities | $15,220,000 | $37,765,000 | $14,823,000 | $10,249,000 |
| Payables And Accrued Expenses | $315,681,000 | $231,930,000 | $172,880,000 | $172,880,000 |
| Payables | $175,868,000 | $89,572,000 | $78,816,000 | $74,916,000 |
| Accounts Payable | $175,868,000 | $89,572,000 | $78,816,000 | $74,916,000 |
| Equity | ||||
| Common Stock Equity | $2,401,052,000 | $2,402,249,000 | $3,145,305,000 | $3,043,162,000 |
| Total Equity Gross Minority Interest | $2,401,052,000 | $2,402,249,000 | $3,145,305,000 | $3,043,162,000 |
| Stockholders Equity | $2,401,052,000 | $2,402,249,000 | $3,145,305,000 | $3,043,162,000 |
| Gains Losses Not Affecting Retained Earnings | $2,358,000 | $-944,000 | $1,428,000 | $-5,236,000 |
| Other Equity Adjustments | $2,358,000 | $-944,000 | $1,428,000 | $-5,236,000 |
| Retained Earnings | $-4,705,981,000 | $-4,498,032,000 | $-3,469,175,000 | $-3,265,026,000 |
| Other | ||||
| Ordinary Shares Number | $190,802,322 | $185,616,438 | $181,364,180 | $177,925,631 |
| Share Issued | $190,802,322 | $185,616,438 | $181,364,180 | $177,925,631 |
| Tangible Book Value | $-886,921,000 | $-974,120,000 | $-1,112,211,000 | $-1,259,118,000 |
| Invested Capital | $4,728,229,000 | $4,972,469,000 | $5,509,581,000 | $5,279,268,000 |
| Working Capital | $914,697,000 | $839,236,000 | $679,668,000 | $569,510,000 |
| Capital Lease Obligations | $195,522,000 | $184,538,000 | $190,449,000 | $210,765,000 |
| Total Capitalization | $4,728,229,000 | $4,723,316,000 | $5,459,581,000 | $5,279,268,000 |
| Additional Paid In Capital | $7,102,766,000 | $6,899,368,000 | $6,611,237,000 | $6,311,644,000 |
| Capital Stock | $1,909,000 | $1,857,000 | $1,815,000 | $1,780,000 |
| Common Stock | $1,909,000 | $1,857,000 | $1,815,000 | $1,780,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $161,931,000 | $157,133,000 | $161,070,000 | $182,399,000 |
| Current Capital Lease Obligation | $33,591,000 | $27,405,000 | $29,379,000 | $28,366,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $276,660,000 | $185,934,000 | $247,619,000 | $201,252,000 |
| Current Accrued Expenses | $139,813,000 | $142,358,000 | $94,064,000 | $97,964,000 |
| Goodwill | $2,368,048,000 | $2,366,676,000 | $2,367,120,000 | $2,346,040,000 |
| Net PPE | $830,996,000 | $810,625,000 | $842,062,000 | $851,759,000 |
| Accumulated Depreciation | $-604,128,000 | $-508,574,000 | $-417,203,000 | $-307,591,000 |
| Gross PPE | $1,435,124,000 | $1,319,199,000 | $1,259,265,000 | $1,159,350,000 |
| Leases | $257,503,000 | $227,885,000 | $214,562,000 | $200,588,000 |
| Construction In Progress | $84,142,000 | $89,065,000 | $104,592,000 | $68,398,000 |
| Other Properties | $122,332,000 | $116,952,000 | $143,708,000 | $167,003,000 |
| Machinery Furniture Equipment | $668,914,000 | $583,057,000 | $494,181,000 | $423,287,000 |
| Buildings And Improvements | $290,777,000 | $290,777,000 | $290,777,000 | $288,941,000 |
| Land And Improvements | $11,456,000 | $11,463,000 | $11,445,000 | $11,133,000 |
| Properties | $0 | $0 | $0 | $0 |
| Work In Process | $90,485,000 | $92,653,000 | $68,882,000 | $57,052,000 |
| Raw Materials | $75,716,000 | $69,730,000 | $58,593,000 | $61,207,000 |
| Other Short Term Investments | $8,715,000 | $437,137,000 | $172,266,000 | $389,564,000 |
| Finished Goods | - | - | - | $57,052,000 |
Fetched: 2026-03-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $356,782,000 | $74,547,000 | $31,929,000 | $-438,021,000 |
| Operating Activities | ||||
| Operating Cash Flow | $491,438,000 | $210,536,000 | $156,119,000 | $-223,559,000 |
| Cash Flow From Continuing Operating Activities | $491,438,000 | $210,536,000 | $156,119,000 | $-223,559,000 |
| Operating Gains Losses | $-3,081,000 | $-7,541,000 | $-14,422,000 | $35,018,000 |
| Investing Activities | ||||
| Capital Expenditure | $-134,656,000 | $-135,989,000 | $-124,190,000 | $-214,462,000 |
| Investing Cash Flow | $195,121,000 | $-442,155,000 | $49,679,000 | $74,066,000 |
| Cash Flow From Continuing Investing Activities | $195,121,000 | $-442,155,000 | $49,679,000 | $74,066,000 |
| Net Other Investing Changes | $-46,732,000 | $-45,225,000 | $-250,000 | $24,451,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-338,090,000 | $231,874,000 | $159,766,000 | $76,485,000 |
| Cash Flow From Continuing Financing Activities | $-338,090,000 | $231,874,000 | $159,766,000 | $76,485,000 |
| Net Other Financing Charges | $-117,364,000 | $-17,754,000 | $-9,751,000 | $-5,530,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-249,172,000 | $-50,000,000 | $0 | $0 |
| Issuance Of Debt | $0 | $266,750,000 | $137,976,000 | $50,000,000 |
| Interest Paid Supplemental Data | $30,444,000 | $27,839,000 | $18,776,000 | $11,519,000 |
| End Cash Position | $955,996,000 | $606,636,000 | $609,675,000 | $242,790,000 |
| Beginning Cash Position | $606,636,000 | $609,675,000 | $242,790,000 | $315,768,000 |
| Effect Of Exchange Rate Changes | $891,000 | $-3,294,000 | $1,321,000 | $30,000 |
| Changes In Cash | $348,469,000 | $255,000 | $365,564,000 | $-73,008,000 |
| Proceeds From Stock Option Exercised | $28,446,000 | $32,878,000 | $31,541,000 | $32,015,000 |
| Net Issuance Payments Of Debt | $-249,172,000 | $216,750,000 | $137,976,000 | $50,000,000 |
| Net Long Term Debt Issuance | $-249,172,000 | $216,750,000 | $137,976,000 | $50,000,000 |
| Long Term Debt Payments | $-249,172,000 | $-50,000,000 | $0 | $0 |
| Long Term Debt Issuance | $0 | $266,750,000 | $137,976,000 | $50,000,000 |
| Net Investment Purchase And Sale | $376,509,000 | $-260,941,000 | $226,532,000 | $278,763,000 |
| Sale Of Investment | $572,277,000 | $205,821,000 | $382,950,000 | $453,072,000 |
| Purchase Of Investment | $-195,768,000 | $-466,762,000 | $-156,418,000 | $-174,309,000 |
| Net Business Purchase And Sale | $0 | $0 | $-52,413,000 | $-14,686,000 |
| Purchase Of Business | $0 | $0 | $-52,413,000 | $-14,686,000 |
| Net PPE Purchase And Sale | $-134,656,000 | $-135,989,000 | $-124,190,000 | $-214,462,000 |
| Purchase Of PPE | $-134,656,000 | $-135,989,000 | $-124,190,000 | $-214,462,000 |
| Change In Working Capital | $121,825,000 | $-56,012,000 | $-342,000 | $-26,377,000 |
| Change In Other Current Liabilities | $-33,760,000 | $-16,057,000 | $-20,368,000 | $-21,970,000 |
| Change In Other Current Assets | $-5,794,000 | $-2,323,000 | $-11,618,000 | $-84,000 |
| Change In Payables And Accrued Expense | $214,042,000 | $43,538,000 | $82,750,000 | $-52,180,000 |
| Change In Inventory | $-3,772,000 | $-34,911,000 | $-7,690,000 | $-13,231,000 |
| Change In Receivables | $-48,891,000 | $-46,259,000 | $-43,416,000 | $61,088,000 |
| Changes In Account Receivables | $-48,891,000 | $-46,259,000 | $-43,416,000 | $61,088,000 |
| Other Non Cash Items | $135,742,000 | $13,861,000 | $-62,554,000 | $-17,143,000 |
| Stock Based Compensation | $217,666,000 | $214,885,000 | $231,312,000 | $206,823,000 |
| Asset Impairment Charge | $7,200,000 | $869,460,000 | $621,000 | $15,969,000 |
| Deferred Tax | $-1,544,000 | $-10,119,000 | $-955,000 | $-11,901,000 |
| Deferred Income Tax | $-1,544,000 | $-10,119,000 | $-955,000 | $-11,901,000 |
| Depreciation Amortization Depletion | $221,579,000 | $214,859,000 | $206,608,000 | $197,558,000 |
| Depreciation And Amortization | $221,579,000 | $214,859,000 | $206,608,000 | $197,558,000 |
| Amortization Cash Flow | $96,700,000 | $95,158,000 | $92,160,000 | $97,450,000 |
| Amortization Of Intangibles | $96,700,000 | $95,158,000 | $92,160,000 | $97,450,000 |
| Depreciation | $124,879,000 | $119,701,000 | $114,448,000 | $100,108,000 |
| Gain Loss On Investment Securities | $-3,081,000 | $2,713,000 | $-4,098,000 | $21,774,000 |
| Net Income From Continuing Operations | $-207,949,000 | $-1,028,857,000 | $-204,149,000 | $-623,506,000 |
| Change In Other Working Capital | - | - | - | $-1,408,000 |
| Unrealized Gain Loss On Investment Securities | - | - | - | $11,774,000 |
| Amortization Of Securities | - | - | - | $1,845,000 |
| Gain Loss On Sale Of PPE | - | - | - | $1,863,000 |
Fetched: 2026-03-22